Protein C1orf111 as a Drug Target: Implications for the Treatment of Inflammatory Diseases

Target Name: SPATA46

NCBI ID: G284680

SPATA46

Protein C1orf111 as a Drug Target: Implications for the Treatment of Inflammatory Diseases

Abstract:
SPATA46 (short for SPTAN1-associated protein 46) is a non-coding RNA molecule located in the nucleus of human cells. It has been identified as a potential drug target and biomarker for the treatment of inflammatory diseases due to its unique structure and various post -transcriptional modifications. This article will discuss the current understanding of SPATA46, its potential as a drug target, and its potential as a biomarker for the diagnosis and treatment of inflammatory diseases.

Introduction:
Inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, and chronic obstructive pulmonary disease (COPD), cause significant morbidity and mortality worldwide. The immune system's response to inflammation is often accompanied by an overreaction, leading to tissue damage and chronic inflammation. Regulation of this response is critical for maintaining tissue homeostasis and preventing disease progression. The non-coding RNA molecule SPATA46 has been identified as a potential drug target and biomarker for the treatment of inflammatory diseases due to its unique structure and various post-transcriptional modifications.

Structure and Function of SPATA46:
SPATA46 is a non-coding RNA molecule that is located in the nucleus of human cells. It has a unique structure, with a 19-nt long poly(A) tail and a 5'-end that is rich in conserved amino acid sequence. SPATA46 has been shown to have various post-transcriptional modifications, including alterations in its stability, translation efficiency, and levels in different cell types.

SPATA46 has been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and transcriptional regulation. It has been shown to interact with various protein molecules, including nuclear factor of activating transcription (NFAT), nuclear factor kappa B (NF-kappa-B), and transcription factor binding protein (TBP). SPATA46 exhibits a variety of different functions on these molecules, such as transcription regulation, DNA binding, and phosphorylation.

SPATA46 as a Drug Target:
SPATA46's unique structure and various post-transcriptional modifications make it an attractive drug target. Currently, several studies have shown that SPATA46 can be targeted by small molecules, including inhibitors of the NF-kappa-B pathway, which is known to play a role in the regulation of inflammation.

SPATA46 has also been shown to interact with the protein kinase PDK4, which is a key regulator of cell growth and survival. The interaction between SPATA46 and PDK4 has been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and angiogenesis. In addition, SPATA46 can also interact with PDK4-specific inhibitors, substrates of PDK4, which provides new ideas for the development of SPATA46 drugs.

SPATA46 as a Biomarker:
SPATA46 has been shown to have various post-transcriptional modifications, including alterations in its stability, translation efficiency, and levels in different cell types. These modifications can affect the stability, translation efficiency, and expression levels of SPATA46, thereby affecting the function of SPATA46. Therefore, SPATA46 can be used as a potential biomarker for detecting and monitoring the development and treatment effects of inflammatory diseases.

The detection and monitoring of SPATA46 can be carried out through a variety of methods, including qRT-PCR, Western blotting and immunofluorescence staining. These methods can not only detect the expression level of SPATA46, but also detect the modification level of SPATA46, such as phosphorylation, methylation, etc. These results can be used to evaluate the role of SPATA46 in the treatment of inflammatory diseases.

Protein Name: Spermatogenesis Associated 46

Functions: Plays a role in spermiogenesis and fertilization

The "SPATA46 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPATA46 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets